Emerging treatments in Neurogastroenterology: Perspectives of guanylyl cyclase C agonists use in functional gastrointestinal disorders and inflammatory bowel diseases

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2982|27|8|1057-1068

ISSN： 1350-1925

Source： NEUROGASTROENTEROLOGY & MOTILITY (ELECTRONIC), Vol.27, Iss.8, 2015-08, pp. : 1057-1068

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Guanylyl cyclase C as a biomarker in colorectal cancer

By Hyslop Terry   Waldman Scott A  

Biomarkers in Medicine, Vol. 7, Iss. 1, 2013-02 ,pp. : 159-167

Future Medicine

Access to resources Recommend Favorite

Emerging treatments in Neurogastroenterology: relamorelin: a novel gastrocolokinetic synthetic ghrelin agonist

By  

NEUROGASTROENTEROLOGY & MOTILITY (ELECTRONIC), Vol. 27, Iss. 3, 2015-03 ,pp. : 324-332

John Wiley & Sons Inc

Access to resources Recommend Favorite

Rationale for the use of rifaximin in inflammatory bowel diseases based on clinical trial results

By Lorenzetti Roberto   Prantera Cosimo  

Clinical Investigation, Vol. 3, Iss. 12, 2013-12 ,pp. : 1187-1193

Future Science

Access to resources Recommend Favorite

Non‐enteric infections, antibiotic use, and risk of development of functional gastrointestinal disorders

By  

NEUROGASTROENTEROLOGY & MOTILITY (ELECTRONIC), Vol. 27, Iss. 11, 2015-11 ,pp. : 1580-1586

John Wiley & Sons Inc

Access to resources Recommend Favorite

Alexithymia and Functional Gastrointestinal Disorders

By  

Psychotherapy and Psychosomatics, Vol. 68, Iss. 5, 1999-09 ,pp. : 263-269

Karger

Access to resources Recommend Favorite